| Steven Warren Crawford, MD | |
|
3535 Pentagon Blvd, Suite 220, Beavercreek, OH 45431-1705 | |
| (937) 429-7350 | |
| (937) 439-7400 |
| Full Name | Steven Warren Crawford |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 31 Years |
| Location | 3535 Pentagon Blvd, Beavercreek, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386603611 | NPI | - | NPPES |
| 0978796 | Medicaid | OH | |
| 000000387044 | Other | OH | ANTHEM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 35067148 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Soin Medical Center | Beaver creek, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kettering Independent Medical Group Inc | 3173710936 | 586 |
News Archive
Male homosexuality doesn't make complete sense from an evolutionary point of view. It appears that the trait is heritable, but because homosexual men are much less likely to produce offspring than heterosexual men, shouldn't the genes for this trait have been extinguished long ago? What value could this sexual orientation have, that it has persisted for eons even without any discernible reproductive advantage?
Shire plc, the global specialty biopharmaceutical company, today announced that a Phase 3b study published in Behavioral and Brain Functions found adults with Attention Deficit Hyperactivity Disorder who took once-daily Vyvanse (lisdexamfetamine dimesylate) Capsules CII demonstrated significant improvement in attention.
The U.S. Patent and Trademark Office granted a patent today to Bellacure, Inc. for its knee pain treatment device, which was designed to allow the patient to reproducibly apply a therapeutic force that urges the femur and tibia apart on the affected side of the knee at an unmatched intensity level while maximizing force efficiency and minimizing weight (United States Patent 7,662,122).
The United States Patent and Trademark Office has awarded Glytec two more patent allowances acknowledging the unique characteristics of its disruptive innovations.
› Verified 1 days ago
| Entity Name | Alliance Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437125572 PECOS PAC ID: 0840104360 Enrollment ID: O20031118000529 |
News Archive
Male homosexuality doesn't make complete sense from an evolutionary point of view. It appears that the trait is heritable, but because homosexual men are much less likely to produce offspring than heterosexual men, shouldn't the genes for this trait have been extinguished long ago? What value could this sexual orientation have, that it has persisted for eons even without any discernible reproductive advantage?
Shire plc, the global specialty biopharmaceutical company, today announced that a Phase 3b study published in Behavioral and Brain Functions found adults with Attention Deficit Hyperactivity Disorder who took once-daily Vyvanse (lisdexamfetamine dimesylate) Capsules CII demonstrated significant improvement in attention.
The U.S. Patent and Trademark Office granted a patent today to Bellacure, Inc. for its knee pain treatment device, which was designed to allow the patient to reproducibly apply a therapeutic force that urges the femur and tibia apart on the affected side of the knee at an unmatched intensity level while maximizing force efficiency and minimizing weight (United States Patent 7,662,122).
The United States Patent and Trademark Office has awarded Glytec two more patent allowances acknowledging the unique characteristics of its disruptive innovations.
› Verified 1 days ago
| Entity Name | Kettering Independent Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629387865 PECOS PAC ID: 3173710936 Enrollment ID: O20101207000425 |
News Archive
Male homosexuality doesn't make complete sense from an evolutionary point of view. It appears that the trait is heritable, but because homosexual men are much less likely to produce offspring than heterosexual men, shouldn't the genes for this trait have been extinguished long ago? What value could this sexual orientation have, that it has persisted for eons even without any discernible reproductive advantage?
Shire plc, the global specialty biopharmaceutical company, today announced that a Phase 3b study published in Behavioral and Brain Functions found adults with Attention Deficit Hyperactivity Disorder who took once-daily Vyvanse (lisdexamfetamine dimesylate) Capsules CII demonstrated significant improvement in attention.
The U.S. Patent and Trademark Office granted a patent today to Bellacure, Inc. for its knee pain treatment device, which was designed to allow the patient to reproducibly apply a therapeutic force that urges the femur and tibia apart on the affected side of the knee at an unmatched intensity level while maximizing force efficiency and minimizing weight (United States Patent 7,662,122).
The United States Patent and Trademark Office has awarded Glytec two more patent allowances acknowledging the unique characteristics of its disruptive innovations.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven Warren Crawford, MD 3535 Pentagon Blvd, Suite 220, Beavercreek, OH 45431-1705 Ph: (937) 429-7350 | Steven Warren Crawford, MD 3535 Pentagon Blvd, Suite 220, Beavercreek, OH 45431-1705 Ph: (937) 429-7350 |
News Archive
Male homosexuality doesn't make complete sense from an evolutionary point of view. It appears that the trait is heritable, but because homosexual men are much less likely to produce offspring than heterosexual men, shouldn't the genes for this trait have been extinguished long ago? What value could this sexual orientation have, that it has persisted for eons even without any discernible reproductive advantage?
Shire plc, the global specialty biopharmaceutical company, today announced that a Phase 3b study published in Behavioral and Brain Functions found adults with Attention Deficit Hyperactivity Disorder who took once-daily Vyvanse (lisdexamfetamine dimesylate) Capsules CII demonstrated significant improvement in attention.
The U.S. Patent and Trademark Office granted a patent today to Bellacure, Inc. for its knee pain treatment device, which was designed to allow the patient to reproducibly apply a therapeutic force that urges the femur and tibia apart on the affected side of the knee at an unmatched intensity level while maximizing force efficiency and minimizing weight (United States Patent 7,662,122).
The United States Patent and Trademark Office has awarded Glytec two more patent allowances acknowledging the unique characteristics of its disruptive innovations.
› Verified 1 days ago
Neetu Gupta, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3535 Pentagon Blvd Ste 220, Beavercreek, OH 45431 Phone: 937-429-7350 | |
Dr. Christopher Joseph Strauchon, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2510 Commons Blvd Ste 230, Beavercreek, OH 45431 Phone: 937-436-9825 Fax: 937-433-6508 | |
Dr. Cassandra Noel Graybill, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3535 Pentagon Blvd Ste 220, Beavercreek, OH 45431 Phone: 937-429-7350 Fax: 937-431-2623 | |
Dr. Valerie Ann Crawford, D.O. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3535 Pentagon Blvd, Suite 220, Beavercreek, OH 45431 Phone: 937-429-7350 Fax: 937-439-7400 | |
Lindsay Nicole Wardle, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3535 Pentagon Blvd, Suite 220, Beavercreek, OH 45431 Phone: 937-429-7350 Fax: 937-439-7400 | |
Dr. Keith Michael Reisinger-kindle, DO, MPH, MS Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 725 University Blvd, Beavercreek, OH 45324 Phone: 937-245-7200 |